You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Printed Wideband Metamaterial Antennas for Ballistic Panels
SBC: APPLIED NANOTECH, INC. Topic: N10AT021The U.S. Navy has initiated a program to develop the next-generation Joint Counter Radio Controlled Improvised Explosive Device Electronic Warfare (JCREW) 3.3 system to detect and jam enemy improvised explosive devices (IEDs). The objective of this propos
STTR Phase II 2013 Department of DefenseNavy -
Highly selective detection of tau oligomers in biological fluids for the diagnosis of Alzheimer's Disease
SBC: Amprion, Inc. Topic: NIAThis proposal is for a phase I/II fast track project for the STTR program with the main goal to develop a test for high sensitive detection of tau oligomers in biological fluids, which could be used for the biochemical diagnosis of Alzheimer’s disease (AD) and related tauopathies. AD is the most common dementia in the elderly population and one of the leading causes of death in the developed wor ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Optogenetic Multiparametric Assay for HT Cardiotoxicity Testing
SBC: VALA SCIENCES, INC. Topic: NHLBIDESCRIPTION (provided by applicant): Monitoring physiology of individual cardiomyocytes in high throughput has not been reported. The inability to perform high throughput physiological measurements limits many basic and applied studies, including the use of stem cell derived cardiomycoytes in cardiotoxicity testing. Current automated cardiotoxicity tests have poor predictive value because they use ...
STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Multipurpose reversible terminators
SBC: FIREBIRD BIOMOLECULAR SCIENCES LLC Topic: NHGRIDESCRIPTION (provided by applicant): This Phase 2 STTR application will allow the Foundation for Applied Molecular Evolution (FfAME) to complete its transfer of technology to Firebird Biomolecular Sciences LLC, allowing Firebird to commercialize nucleoside triphosphates where the 3'-OH groups are blocked by a 3'-ONH2 group. Triphosphates having this modification are accepted by DNA polymerases and ...
STTR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health -
Optical photothermal IR (O-PTIR) microscopy for chemical imaging of living cells at sub-micron resolution
SBC: PHOTOTHERMAL SPECTROSCOPY CORP. Topic: 102Optical photothermal IR (OPTIR) microscopy for chemical imaging of living cells at sub-micron resolution Project Summary/Abstract Photothermal Spectroscopy Corp (PSC) and Prof. Ji-Xin Cheng of Boston University in collaboration with Prof. Rohith Reddy (University of Houston) propose to develop, validate, and commercialize a novel technical called Optical Photothermal Infrared (OPTIR) spectroscopy. ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Compatibility between Brain-Computer Interface and High-Efficiency Augmentative and Alternative Communication Systems
SBC: Prentke Romich Company Topic: NIDCDCompatibility between Brain-Computer Interface and High Efficiency Augmentative and AlternativeCommunication Systems: Phase II ABSTRACT Brain-computer interfaces (BCI) enable text production for people who cannot move, but have only simple communication interfaces and are not widely used. Augmentative and alternative communication (AAC) systems are widely used and give efficient and precise commun ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Low-cost, Time-resolved Chemical Characterization of Atmospheric Aerosols
SBC: AEROSOL DEVICES INC Topic: 23bThe composition of atmospheric particulate matter (“aerosols”) strongly influences health and environmental impacts, but there exist few time-resolved, long-term records of particle-phase chemical composition due to lack of appropriate monitoring tools. Needed is an instrument that is robust, easy-to-operate, with automated calibrations and data reduction, to provide operationally-inexpensive ...
STTR Phase II 2019 Department of Energy -
Low Cost Alloys for Magnetocaloric Refrigeration
SBC: GENERAL ENGINEERING & RESEARCH, L.L.C. Topic: 12bReplacement of petroleum based vehicles with fuel cell electric vehicles operating on hydrogen produced from domestically available resources would dramatically decrease emissions of greenhouse gases and other pollutants as well as reduce dependence on oil from politically volatile regions of the world. One major inhibitor to a hydrogen society is the lack of infrastructure, which requires hydroge ...
STTR Phase II 2019 Department of Energy -
Characterization of human antibodies to sialyl-Lewis A (sLeA) derived from patien
SBC: MABVAX THERAPEUTICS, INC. Topic: NCIDESCRIPTION (provided by applicant): The carbohydrate antigen sialyl-Lewis a (sLea) is widely expressed on epithelial tumors of the gastrointestinal tract, on breast cancer cells, and also on small cell lung cancer cells but is expressed minimally or not at all on normal tissues. sLea serves as a ligand for epithelial leukocyte adhesion molecules and higher expression of sLea was observed in patie ...
STTR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health -
In Vivo Studies of a Novel HDAC Inhibitor for Treating Hemoglobin Disorders
SBC: CETYA THERAPEUTICS, INC. Topic: NHLBIPROJECT SUMMARY The β-hemoglobinopathies are prevalent genetic blood diseases with few treatment options. It is estimate that 7% of the worldandapos;s population carries an abnormal hemoglobin gene with 400,000 infants born annually with a severe life threatening hemoglobinopathy. Drug mediated induction of normal, but developmentally silenced, fetal hemoglobin (HbF) expression reduces anemia and ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health